Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibiting COMT in Parkinson's Disease A Monocenter, Observational, Rater-blinded Trial of Entacapone in Parkinson's Disease

NCT02070887 is registered in ClinicalTrials.gov with Christian Baumann as lead sponsor.

NCT NCT02070887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibiting COMT in Parkinson's Disease A Monocenter, Observational, Rater-blinded Trial of Entacapone in Parkinson's Disease
Lead sponsor
Christian Baumann
Phase
Observational
Overall status
Withdrawn
Start date
February 28, 2014
Completion date
September 30, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease